Hyperglycemia leads to poorer clinical outcomes, with increased morbidity and mortality in both critically ill and non-critically ill people. Improving blood glucose levels reduces length of hospital stay, systemic infections and short- and long-term mortality. Egyptian physicians evaluated the efficacy of insulin degludec compared to insulin glargine and regular insulin in controlling blood glucose levels.
You May Also Like
- Myelofibrosis
New treatment options for myelofibrosis patients with a high risk of anemia?
- Chronic insomnia in adults: Guideline recommendations
CBT-i as first choice – pharmacotherapy as secondary intervention
- COPD therapy
Drug therapy – Update 2025
- Pulmonary hypertension
PH and lung diseases
- Focus on prevention
Colorectal cancer screening – an update
- IBDmatters - Synergy effects for IBD pathways
How combination therapies lead to better treatment results
- Chronic hand eczema
Topical pan-JAK-i vs. systemic retinoid: head-to-head study
- Study report